MOSCOW (MRC) -- Evonik has raised the prices for its aliphatic diisocyanates and derivatives, offered under the brand names VESTANAT and VESTAGON up to 10% on a global basis with immediate effect, as per the company's press release.
All existing contracts will be honored.
After many years of stable prices the price increase has become unavoidable to compensate higher costs for personnel, maintenance, regulatory affairs and logistics.
This adjustment will enable the business line Crosslinkers to continue to provide to its customers a superior quality, excellent service with special focus on supply reliability and the
As MRC informed earlier, Evonik is expanding its production facilities in Birmingham (Alabama, USA) and Darmstadt (Germany). This will create additional capacity for the production of biodegradable polymers marketed globally under the brand names RESOMER and RESOMER SELECT. These poly-lactic-glycolic-acid (PLGA) copolymers are primarily used to manufacture bioresorbable medical devices and controlled-release formulations for parenteral drug delivery.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world.
MRC